Olaris aims to fundamentally change how diseases are diagnosed and treated. With their pioneering metabolomics platform and machine learning algorithms, they produce personalized “Biomarkers of Response” (BoR) to readily differentiate drug responders (R) from non-responders (NR).
Colossal Biosciences
9 followers
Vera Therapeutics
6 followers
Mineralys Therapeutics
3 followers
CG Oncology
2 followers
Generate Biomedicines
5 followers
Gloucester Marine Genomics Institute
1 follower
HydroPeptide LLC
4 followers
BioAge
3 followers
Thermo Fisher Scientific
286 followers
Genentech
226 followers
Gilead Sciences
214 followers
Regeneron
183 followers